课题基金 / 基金详情

Understanding the real-world impact of the use of three alternate nicotine-delivery products on combustible cigarette use

Understanding the real-world impact of the use of three alternate nicotine-delivery products on combustible cigarette use
了解使用三种替代尼古丁输送产品对可燃卷烟使用的现实影响
批准号:
9927613
负责人:
Megan E Piper
金额:
$46.49万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-08 至 2022-04-30

项目摘要

项目成果

Megan E Piper的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 在美国,吸烟每年导致无数的疾病和约50万人死亡,其中三分之一的人死于吸烟。 所有癌症死亡。尼古丁是烟草中导致持续吸烟的主要物质。新兴产品 例如电子香烟,允许吸烟者以各种形式自我施用尼古丁, 伤害FDA概述了一种新的双管齐下的方法,重点是规范尼古丁本身。的目标 这项研究是为了了解这两个新的FDA战略的潜在影响:1)确保 更安全的替代尼古丁输送系统(ANDS)的可用性,以及2)减少 将可燃性香烟降低到不上瘾的水平。具体来说,我们将研究如何以及电子烟和非常低 尼古丁香烟(VLNC)可以在现实环境中替代可燃香烟, 受尼古丁贴片的稳态尼古丁影响。在这项混合设计研究中,180名每日吸烟的成年人 不打算戒烟的受试者将被随机分配到受试者间的三个水平之一 因素:1)VLNC; 2)Juul电子烟;或3)无替代产品。在两个不同的星期,参与者将 要求他们放弃常规香烟,仅使用研究产品。他们还将被要求使用 活性尼古丁或安慰剂贴剂(受试者内因素),以双盲方式提供, 平衡的秩序。参与者将记录每次使用自己的香烟或任何替代品的时间 产品,通过智能手机进行真实的实时操作,并且对于某些使用事件,回答有关使用环境的问题 (e.g.,影响,允许吸烟)和驱动使用行为的可能机制(例如,戒断缓解, 满足感、品味)。我们还将研究个人因素的影响,如性别,依赖, 精神共病和危险认知对使用行为的影响。这项研究将提供关键信息 关于尼古丁和ANDS(含或不含尼古丁)非成瘾性水平香烟的影响 替代,在现实世界中吸烟者使用他们常用的香烟和其他结果。这些数据 可以告知有关ANDS和非ANDS的潜在公共卫生影响的监管政策决定, 上瘾的香烟
英文摘要
Project Summary Smoking causes myriad diseases and ~500,000 deaths in the United States each year, including one-third of all cancer deaths. Nicotine is the chief agent in tobacco responsible for continued smoking. Emerging products such as e-cigarettes allow smokers to self-administer nicotine in a variety of forms and on a continuum of harm. The FDA has outlined a new two-pronged approach focusing on regulating nicotine per se. The goal of this research is to understand the potential impact of these two new FDA strategies: 1) to ensure the availability of safer alternative nicotine delivery systems (ANDS), and 2) to reduce the nicotine content in combustible cigarettes to non-addictive levels. Specifically, we will examine how well e-cigarettes and very low nicotine cigarettes (VLNCs) can substitute for combustible cigarettes in real-world settings and whether this is influenced by steady-state nicotine from a nicotine patch. For this mixed design study, 180 daily adult smokers who are not planning to quit smoking will be randomly assigned to one of three levels of the between-subjects factor: 1) VLNCs; 2) Juul e-cigarettes; or 3) no alternative product. During two different weeks, participants will be asked to switch from their usual cigarettes and use only study products. They will also be asked to use either an active nicotine or placebo patch (the within-subjects factor), provided in double-blind fashion and counterbalanced order. Participants will record each time they use their own cigarettes or any alternative product, in real time via a smartphone, and, for some use events, answer questions about the use context (e.g., affect, smoking permitted) and possible mechanisms driving use behavior (e.g., withdrawal alleviation, satisfaction, taste). We will also examine the impact of person factors such as sex, dependence, and psychiatric comorbidity and risk perceptions on use behavior. This research will provide critical information regarding the impact of cigarettes with non-addictive levels of nicotine and ANDS, with or without nicotine replacement, in real-world settings on smokers' use of their usual cigarettes and other outcomes. These data could inform regulatory policy decisions regarding the potential public health impact of ANDS and non- addictive cigarettes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the real-world impact of the use of three alternate nicotine-delivery products on combustible cigarette use
  • 批准号:
    10160855
  • 项目类别:
  • 资助金额:
    $46.62万
  • 财政年份:
    2019
  • 负责人:
    Megan E Piper
  • 依托单位:
Project 1: Optimizing Smoking Cessation Treatment in Primary Care: A Factorial Screening Experiment (Cessation Screening)
  • 批准号:
    10415916
  • 项目类别:
  • 资助金额:
    $15.85万
  • 财政年份:
    2014
  • 负责人:
    Megan E Piper
  • 依托单位:
Project 1: Optimizing Smoking Cessation Treatment in Primary Care: A Factorial Screening Experiment (Cessation Screening)
  • 批准号:
    10215420
  • 项目类别:
  • 资助金额:
    $45.01万
  • 财政年份:
    2014
  • 负责人:
    Megan E Piper
  • 依托单位:
A Comparative Effectiveness RCT of Optimized Cessation Treatments
  • 批准号:
    8655745
  • 项目类别:
  • 资助金额:
    $7.33万
  • 财政年份:
    2014
  • 负责人:
    Megan E Piper
  • 依托单位:
海外基金